Genefron

Company Overview

Snapshot

Founded in January 2011 by Yaniv Kotler, Genefron operated with 1-10 employees. The company ceased operations in August 2024.

Business overview

Genefron specializes in developing and producing personalized genomic diagnostic kits. The company leverages gene expression signatures derived from bioinformatic advancements to deliver in-vitro companion diagnostics. Genefron's product portfolio includes fully developed diagnostic kits, which are CE marked and Israeli OTC, targeting viral and autoimmune diseases and therapies such as rheumatoid arthritis, multiple sclerosis, and cytomegalovirus. It operates within the Health Tech & Life Sciences sector, focusing on digital healthcare, medical decision support, and digital medical diagnostics, serving both laboratories and consumers.

Company Intelligence Q&A

What is Genefron's primary focus?

Genefron develops and produces genome-based personalized diagnostic kits, utilizing gene expression signatures from bioinformatic developments for in-vitro companion diagnostics.

When was Genefron founded?

Genefron was founded in January 2011.

Who is the founder of Genefron?

Yaniv Kotler is the founder of Genefron.

What types of diagnostic kits does Genefron offer?

Genefron offers fully developed diagnostic kits (CE marked and Israeli OTC) for viral and autoimmune diseases and therapies, including rheumatoid arthritis, multiple sclerosis, and cytomegalovirus.

What is the current operational status of Genefron?

Genefron ceased to operate in August 2024.